Recombinant Mycoplasma genitalium ATP synthase subunit a (atpB)

What expression systems are most effective for producing recombinant M. genitalium atpB?

For successful expression of recombinant M. genitalium atpB, several expression systems can be employed, with E. coli being the most commonly used for bacterial proteins . When designing an expression system, researchers should consider:

• Vector selection: Bacterial expression vectors such as pBs, pBluescript SK, pTrc99A, and pRIT5 are suitable options . For eukaryotic expression, vectors like pWLneo, pSV2cat, and pSVL can be utilized .

• Fusion tags: Various tags can facilitate purification and potentially improve solubility. Tag types are typically determined during the production process based on protein characteristics .

• Expression optimization: As a membrane protein, atpB expression may benefit from lower temperatures (16-25°C) to improve proper folding and solubility. Optimization of inducer concentration and induction timing is also critical.

• Extraction methods: Since atpB is a membrane protein, specialized detergent-based extraction protocols are necessary to solubilize the protein while maintaining its native conformation.

A methodological approach for expression optimization would include:

• Testing multiple expression strains (BL21(DE3), C41(DE3), C43(DE3))

• Varying induction parameters (temperature, IPTG concentration, duration)

• Screening different solubilization detergents

• Comparing various affinity tags and their positions (N-terminal vs. C-terminal)

What are the optimal storage conditions for recombinant M. genitalium atpB?

Based on product information, the following storage conditions are recommended for maintaining recombinant M. genitalium atpB stability and activity:

• Short-term storage: Store at -20°C

• Long-term storage: Use -20°C or -80°C for extended preservation

• Working aliquots: Can be maintained at 4°C for up to one week

• Buffer composition: A Tris-based buffer containing 50% glycerol, specifically optimized for this protein

Important methodological considerations include:

• Avoiding repeated freeze-thaw cycles, which can lead to protein denaturation and reduced activity

• Preparing small aliquots of purified protein to minimize freeze-thaw events

• Adding protease inhibitors if degradation is observed during storage

• Validating protein activity after storage periods to ensure functionality is maintained

How can researchers verify the identity and purity of recombinant M. genitalium atpB?

Verification of recombinant M. genitalium atpB identity and purity requires a multi-method approach:

• SDS-PAGE analysis: Should show a single predominant band at approximately 52.5 kDa, corresponding to the expected molecular weight of atpB .

• Western blotting: Using anti-His tag antibodies (if His-tagged) or specific anti-atpB antibodies to confirm identity.

• Mass spectrometry: Peptide mass fingerprinting or tandem MS can verify the protein sequence against the expected M. genitalium atpB sequence:

  • Tryptic digestion followed by LC-MS/MS

  • MALDI-TOF analysis for molecular weight confirmation

• Functional assays: ATP synthase activity assays to confirm that the protein retains functional properties.

• Circular dichroism: To verify proper folding through secondary structure analysis.

A standardized quality control protocol should include:

• Purity assessment (>90% by densitometry from SDS-PAGE)

• Identity confirmation by at least two independent methods

• Batch-to-batch consistency verification

• Endotoxin testing if the protein will be used in cell culture experiments

What techniques are available for studying the interaction between M. genitalium atpB and other ATP synthase subunits?

Investigating protein-protein interactions involving M. genitalium atpB requires specialized approaches suitable for membrane proteins:

• Co-immunoprecipitation (Co-IP): Using antibodies against atpB to pull down interacting partners, particularly other ATP synthase subunits. This approach can identify native protein complexes.

• Crosslinking studies: Chemical crosslinkers can stabilize transient interactions between atpB and other subunits, followed by mass spectrometry to identify crosslinked residues.

• Surface plasmon resonance (SPR): For quantitative measurement of binding kinetics between purified atpB and other purified subunits.

• Förster resonance energy transfer (FRET): Labeling atpB and potential interacting partners with fluorophores to detect proximity in live cells or reconstituted systems.

• Bacterial two-hybrid systems: Modified for membrane proteins to detect binary interactions between atpB and other ATP synthase components.

• Cryo-electron microscopy: For structural characterization of the intact ATP synthase complex, revealing the position and interactions of atpB within the assembly.

Methodological considerations should include:

• Careful selection of detergents that maintain protein-protein interactions

• Controls to distinguish specific from non-specific interactions

• Validation of results using multiple complementary techniques

• Comparison with known interactions of ATP synthase subunits from better-characterized organisms

How does ATP synthase function in M. genitalium differ from other bacteria due to its minimal genome?

M. genitalium possesses one of the smallest genomes of any free-living organism (~580 kb with approximately 480 protein-coding genes) , raising intriguing questions about its energy metabolism. Several key differences in ATP synthase function can be observed:

Methodological approaches to investigate these differences include:

This research has implications for understanding the minimal requirements for cellular life and could inform synthetic biology efforts to create minimal cells.

What is the role of M. genitalium atpB in pathogenesis and how might it be exploited for therapeutic development?

While not directly addressed in the search results, the essential nature of ATP synthase for bacterial survival makes atpB a potential therapeutic target. A methodological framework for investigating this includes:

• Expression analysis during infection:

  • Measure atpB expression levels during different stages of infection

  • Compare expression in antibiotic-sensitive versus resistant strains

  • Correlate expression with virulence phenotypes

• Target validation approaches:

  • RNA interference or antisense strategies to reduce atpB expression

  • Small molecule inhibitors of ATP synthase activity

  • Assessment of bacterial viability and virulence after targeting atpB

• Immunological relevance:

  • Determine if atpB generates antibody responses during natural infection

  • Assess if anti-atpB antibodies have neutralizing activity

  • Evaluate atpB as a potential vaccine component

• Drug development strategies:

  • High-throughput screening for atpB inhibitors

  • Structure-based drug design targeting unique features of M. genitalium atpB

  • Repurposing of existing ATP synthase inhibitors for M. genitalium

Potential therapeutic applications could be particularly valuable given that M. genitalium infections are becoming increasingly difficult to treat due to antibiotic resistance . ATP synthase inhibitors could represent a novel class of antimicrobials with activity against resistant strains.

How can recombinant M. genitalium atpB be used in developing diagnostic tools for M. genitalium infections?

M. genitalium causes sexually transmitted infections that are often asymptomatic but can lead to complications if left untreated . Recombinant atpB could be valuable in diagnostic development:

• Serological assay development:

  • Similar to approaches used with M. pneumoniae ATP synthase proteins

  • ELISA-based detection of anti-atpB antibodies in patient sera

  • Western blot confirmation tests

  • Lateral flow immunochromatographic assays for point-of-care testing

• Methodological approach for diagnostic validation:

• Advantages of atpB-based diagnostics:

  • Potential to detect past infections (serological memory)

  • Possibly less susceptible to genetic variation than surface antigens

  • Could complement nucleic acid amplification tests (NAATs)

  • May help distinguish between active and resolved infections

Current diagnostic approaches for M. genitalium primarily rely on NAATs, but these cannot distinguish past from current infections and require specialized equipment . Serological tests based on atpB could provide complementary diagnostic information, particularly for epidemiological studies.

What structural modifications of recombinant M. genitalium atpB affect its stability and activity in vitro?

Understanding the structure-function relationship of M. genitalium atpB requires systematic analysis of how modifications affect stability and activity. Though specific data is not provided in the search results, a methodological framework includes:

• Site-directed mutagenesis studies:

  • Target predicted functional residues (proton channel, subunit interfaces)

  • Create systematic alanine scanning to map critical regions

  • Introduce mutations observed in clinical isolates to assess functional impact

• Domain engineering approaches:

  • Generate truncated versions to identify minimal functional domains

  • Create chimeric proteins with atpB from other species

  • Introduce stabilizing modifications (e.g., disulfide bridges)

• Post-translational modification analysis:

  • Identify native modifications (phosphorylation, acetylation)

  • Assess their impact on protein function

  • Engineer modified versions to enhance stability

A comprehensive experimental design would include:

These studies would provide insights into critical regions of atpB for function and identify modifications that could enhance stability for structural studies or biotechnological applications.

How does the expression of atpB correlate with antibiotic resistance in M. genitalium strains?

The relationship between atpB expression and antibiotic resistance represents an unexplored but potentially significant area of research. M. genitalium infections are typically treated with antibiotics such as doxycycline and azithromycin , but resistance is increasing.

A comprehensive methodological approach would include:

• Expression analysis in clinical isolates:

  • Compare atpB expression levels between antibiotic-sensitive and resistant strains

  • Use RT-qPCR and proteomic approaches to quantify expression

  • Correlate expression with minimum inhibitory concentrations (MICs)

• Experimental manipulation:

  • Modulate atpB expression in laboratory strains

  • Assess changes in antibiotic susceptibility

  • Measure ATP levels and membrane potential

• Mechanistic investigations:

  • Determine if ATP-dependent efflux pumps are affected by atpB expression

  • Investigate if membrane potential changes alter antibiotic uptake

  • Explore metabolic adaptations associated with altered ATP synthesis

Potential experimental data collection and analysis:

This research could potentially identify:

• Biomarkers for predicting antibiotic resistance

• New therapeutic targets to combat resistant infections

• Combination therapy strategies involving ATP synthase inhibitors

• Metabolic vulnerabilities in resistant strains